Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Prepaid Assets: 2011-2025

Historic Prepaid Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $1.4 million.

  • Fennec Pharmaceuticals' Prepaid Assets fell 54.37% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 54.37%. This contributed to the annual value of $3.1 million for FY2024, which is 19.61% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Prepaid Assets stood at $1.4 million, which was down 1.55% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Prepaid Assets registered a high of $4.5 million during Q1 2024, and its lowest value of $278,000 during Q3 2022.
  • Over the past 3 years, Fennec Pharmaceuticals' median Prepaid Assets value was $2.4 million (recorded in 2025), while the average stood at $2.3 million.
  • In the last 5 years, Fennec Pharmaceuticals' Prepaid Assets slumped by 77.44% in 2022 and then surged by 858.21% in 2024.
  • Fennec Pharmaceuticals' Prepaid Assets (Quarterly) stood at $1.2 million in 2021, then crashed by 77.44% to $770,000 in 2022, then spiked by 234.42% to $2.6 million in 2023, then rose by 19.61% to $3.1 million in 2024, then slumped by 54.37% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.4 million for Q2 2025, and $2.4 million during Q1 2025.